medigraphic.com
Revista Médica Sinergia

2021, Number 02

<< Back Next >>

Revista Médica Sinergia 2021; 6 (02)

Pediatric anaphylaxis

Hines CKD, Zumbado VR

Language: Spanish
References: 18
Page: 1-13
PDF size: 244.70 Kb.


ABSTRACT

Anaphylaxis is a rapid-onset systemic hypersensitivity reaction that can be fatal if it is not treated properly. Anaphylaxis is the response to the release of inflammatory mediators by both immunological and nonimmunological mechanisms, and can occur after a single exposure to the allergen or after re-exposure in a sensitized patient. The most common triggers are food, drugs, and insect venom, with food being the main triggers in children. However, in 20% of cases the trigger is not identified. The diagnosis of anaphylaxis is clinical; however, it should be noted that it can present with a great variety of symptoms, hence the complexity of its identification. The most common manifestations are skin symptoms such as urticaria, angioedema, erythema, and itching. The absence of these does not rule out anaphylaxis and should not delay treatment. The treatment of choice will be epinephrine, this should be administered immediately in cases where anaphylaxis is suspected, even if the diagnosis is uncertain, because there is no contraindication for its use, and if its use is delayed it can cause fatal outcomes. This article addresses the pathophysiology, epidemiology, diagnosis, and treatment of anaphylaxis, focused on pediatric patients, since this is a population in which this pathology is often underdiagnosed.


REFERENCES

  1. Fustiñana AL, Rino PB, Kohn-Loncarica GA. Reconocimiento y manejo de la Anafilaxia en pediatría. Revista Chilena de Pediatría. 2019;90(1):44-5. https://doi.org/10.32641/rchped.v90i1.839

  2. Atanaskovic MM, Gomes E, Cernadas JR, du Toit G, Kidon M, Kuyucu S, et al. Diagnosis and management of drug‐induced anaphylaxis in children: An EAACI position paper. https://doi.org/10.1111/pai.13034

  3. Reber LL, Hernandez JD, Galli SJ. The Pathophysiology of Anaphylaxis. The Journal of Allergy and Clinical Immunology. 2017 Aug;140(2):335-348.https://doi.org/10.1016/j.jaci.2017.06.003

  4. Thomson H, Seith R, Craig S. Downstream consequences of diagnostic error in pediatric anaphylaxis. BMC Pediatrics. 2018 Feb 7;18(1):40.https://doi.org/10.1186/s12887-018-1024-z

  5. Choi YJ, Kim J, Jung JY, Kwon H, Park JW. Underuse of Epinephrine for Pediatric Anaphylaxis Victims in the Emergency Department: A Population-based Study. Allergy Asthma & Immunology Research. 2019 Jul;11(4):529- 537. https://doi.org/10.4168/aair.2019.11.4.529

  6. Anagnostou K, Turner PJ. Myths, facts and controversies in the diagnosis and management of anaphylaxis. Archives of Disease in Childhood. 2019 Jan;104(1):83-90. https://doi.org/10.1136/archdischild-2018-314867

  7. Anagnostou K. Anaphylaxis in Children: Epidemiology, Risk Factors and Management. Current Pediatric Reviews. 2018;14(3):180-186. https://doi.org/10.2174/1573396314666180507115115

  8. Ramsey NB, Guffey D, Anagnostou K, Coleman NE, Davis CM. Epidemiology of Anaphylaxis in Critically Ill Children in the United States and Canada. The Journal of Allergy and Clinical Immunology in Practice. 2019 Sep- Oct;7(7):2241-2249. https://doi.org/10.1016/j.jaip.2019.04.025

  9. Linzer JF, Bechtel KA. Pediatric Anaphylaxis. Medscape Drugs & Diseases. Updated Sept 15, 2016. Disponible en: https://emedicine.medscape.com/article/799744-overview.

  10. Cheng J. Anaphylaxis: The Underrecognized Killer. Pediatric Emergency Medicine Reports [Internet]. 2017 Aug [cited 2020 Oct 19];22(8):1-21. Disponible en: http://search.ebscohost.com.ezproxy.sibdi.ucr.ac.cr:2048/login.aspx?direct=true&db=asn&AN=124160900&lang =es&site=ehost-live&scope=site

  11. Stepanovic B, Sommerfield D, Lucas M, Ungern SBS. An update on allergy and anaphylaxis in pediatric anesthesia. Pediatric Anesthesia [Internet]. 2019 Sep [cited 2020 Oct 19];29(9):892-900. doi:10.1111/pan.13703. https://doi.org/10.1111/pan.13703

  12. Fischer D, Vander Leek TK, Ellis AK, Kim H. Anaphylaxis. Allergy Asthma & Clinical Immunology. 2018 Sep 12;14(Suppl 2):54. https://doi.org/10.1186/s13223-018-0283-4

  13. Turner PJ, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boyle RJ. Fatal Anaphylaxis: Mortality Rate and Risk Factors. The Journal of Allergy and Clinical Immunology. 2017 Sep-Oct;5(5):1169-1178. https://doi.org/10.1016/j.jaip.2017.06.031

  14. Manuyakorn W, Benjaponpitak S, Kamchaisatian W, Vilaiyuk S, Sasisakulporn C, Jotikasthira W. Pediatric anaphylaxis: triggers, clinical features, and treatment in a tertiary-care hospital. Asian Pacific Journal of Allergy and Immunology. 2015 Dec;33(4):281-8. https://doi.org/10.12932/AP0610.33.4.2015

  15. Pouessel G, Cerbelle V, Lejeune S, Leteurtre S, Ramdane N, Deschildre A, et al. Anaphylaxis admissions in pediatric intensive care units: Follow‐up and risk of recurrence. Pediatric Allergy & Immunology [Internet]. 2019 May [cited 2020 Oct 19];30(3):341-7. https://doi.org/10.1111/pai.13015

  16. Commins SP. Outpatient Emergencies: Anaphylaxis. Medical Clinics of North America. 2017 May;101(3):521-536. https://doi.org/10.1016/j.mcna.2016.12.003

  17. Sicherer SH, Simons FER; SECTION ON ALLERGY AND IMMUNOLOGY. Epinephrine for First-aid Management of Anaphylaxis. Pediatrics. 2017 Mar;139(3):e20164006. https://doi.org/10.1542/peds.2016-4006

  18. Song TT, Lieberman P. Who needs to carry an epinephrine autoinjector? Cleveland Clinic Journal of Medicine. 2019 Jan;86(1):66-72. https://doi.org/10.3949/ccjm.86a.17123




2020     |     www.medigraphic.com